Miscellaneous Urogenital Disorders Archives - Page 2 of 74 - MPR

Miscellaneous Urogenital Disorders

New Indication: Invokana

Invokana is now approved to reduce the risk of end-stage renal disease, doubling of serum creatinine, cardiovascular death, and hospitalization for heart failure in adults with type 2 diabetes and diabetic nephropathy with albuminuria >300mg/day.

MPR Weekly Dose Podcast: Episode 16

In our first episode of 2020 we cover new management guidelines in osteoarthritis; Recommendations for the use of testosterone therapy; The best diets for 2020; Two drug recalls; And a new drug approved for the treatment of migraines.